Germany
Japan
United Kingdom
China
TIMP2 mouse monoclonal capture antibody, validated for ELISA and Luminex assays
| Applications | ELISA, LMNX |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Matched ELISA Pair | TA700235, TA700236, TA700237, TA700238, TA700242 |
Primary Antibodies
View as table Download
USD 458.00
In Stock
USD 458.00
In Stock
purified BTK mouse monoclonal capture antibody, validated for Luminex assays
| Applications | ELISA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Matched ELISA Pair | TA700509 |
USD 458.00
In Stock
purified POSTN mouse monoclonal capture antibody, validated for Luminex assays
| Applications | ELISA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Matched ELISA Pair | TA700050 |
Active filters
Category
-
Antibodies
- Primary Antibodies
Antibody Hosts
- Mouse
Conjugates
- Unconjugated
Assay Platforms
- 96-well plate
Citations
- Yes
Filter by
Target Symbol
Reactivities
Applications
Clonalities
Assay Types
Families
- Druggable Genome (6)
- Secreted Protein (3)
- Transcription Factors (3)
- Protein Kinase (2)
- Transmembrane (2)
- ES Cell Differentiation/IPS (1)
- Embryonic stem cells (1)
- Induced pluripotent stem cells (1)
- Stem cell - Pluripotency (1)
- Stem cell relevant signaling - JAK/STAT signaling pathway (1)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (1)
- Stem cell relevant signaling - Wnt Signaling pathway (1)
Pathways
- MAPK signaling pathway (4)
- Fc epsilon RI signaling pathway (3)
- TGF-beta signaling pathway (3)
- Acute myeloid leukemia (2)
- Alzheimer's disease (2)
- B cell receptor signaling pathway (2)
- Bladder cancer (2)
- Chronic myeloid leukemia (2)
- Citrate cycle (TCA cycle) (2)
- Colorectal cancer (2)
- Endometrial cancer (2)
- ErbB signaling pathway (2)
- Glutathione metabolism (2)
- Metabolic pathways (2)
- NOD-like receptor signaling pathway (2)
- Natural killer cell mediated cytotoxicity (2)
- Pathways in cancer (2)
- Prion diseases (2)
- T cell receptor signaling pathway (2)
- Thyroid cancer (2)
- Toll-like receptor signaling pathway (2)
- Type II diabetes mellitus (2)
- Wnt signaling pathway (2)
- Adherens junction (1)
- Adipocytokine signaling pathway (1)
- Allograft rejection (1)
- Amyotrophic lateral sclerosis (ALS) (1)
- Antigen processing and presentation (1)
- Apoptosis (1)
- Asthma (1)
- Axon guidance (1)
- Cell cycle (1)
- Chemokine signaling pathway (1)
- Cytokine-cytokine receptor interaction (1)
- Dilated cardiomyopathy (1)
- Dorso-ventral axis formation (1)
- Endocytosis (1)
- Fc gamma R-mediated phagocytosis (1)
- Focal adhesion (1)
- Gap junction (1)
- Glioma (1)
- GnRH signaling pathway (1)
- Graft-versus-host disease (1)
- Hematopoietic cell lineage (1)
- Hypertrophic cardiomyopathy (HCM) (1)
- Insulin signaling pathway (1)
- Jak-STAT signaling pathway (1)
- Long-term depression (1)
- Long-term potentiation (1)
- Melanogenesis (1)
- Melanoma (1)
- Neurotrophin signaling pathway (1)
- Non-small cell lung cancer (1)
- Oocyte meiosis (1)
- Pancreatic cancer (1)
- Primary immunodeficiency (1)
- Progesterone-mediated oocyte maturation (1)
- Prostate cancer (1)
- RIG-I-like receptor signaling pathway (1)
- Regulation of actin cytoskeleton (1)
- Renal cell carcinoma (1)
- Small cell lung cancer (1)
- Spliceosome (1)
- Systemic lupus erythematosus (1)
- Type I diabetes mellitus (1)
- VEGF signaling pathway (1)
- Vascular smooth muscle contraction (1)
- mTOR signaling pathway (1)